Unknown

Dataset Information

Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.


ABSTRACT:

Background

Tacrolimus has unpredictable pharmacokinetic (PK) characteristics, which are partially attributed to CYP3A5 polymorphism. The potential effects of clinical factors in the postoperative period of transplantation on tacrolimus PK and those of early tacrolimus PK variability on clinical outcomes are yet to be clarified.

Methods

We examined the genetic and clinical factors affecting early tacrolimus PK variability in 256 kidney transplant recipients. The relationships among tacrolimus exposure, graft function delay (DGF), and acute rejection (AR) were further explored. Findings. The CYP3A5 genotype were strongly associated with tacrolimus concentration/dose ratio (C 0/D). Additionally, ABCB1 (rs1045642 and rs2032582) and ABCC2 (rs374006

SUBMITTER: Cheng F 

PROVIDER: S-EPMC9481373 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature